Abstract
It is estimated that 20% of the adult world population suffers from anxiety. This disease is manifested by sensations of psychic malaise, translated by a variety of somatic disorders related to autonomic hyperactivity. The pharmaceutical industry has a great therapeutic arsenal for anxiety, nevertheless, generating numerous adverse effects on its users. In this way, the search for safer a…